Ollie’s Bargain Outlet Holdings, Inc. (OLLI) has recently received a positive upgrade from analyst Anthony Chukumba of Loop Capital, who initiated a “Buy” rating on December 22, 2025, with a price ...

Eagle Materials Inc. (NYSE: EXP) has garnered attention from investors as Truist Securities analyst Keith Hughes upgraded the ...

Summary • Destination XL Group, Inc. (DXLG) shares fell 7.0% after hours to $0.99 amid regular trading conditions.• The ...

In a significant development for investors, Barclays analyst Pablo Monsivais upgraded Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (VLRS) to an “Overweight” rating o. This comes alongside a ...

Bain Capital Specialty Finance, Inc. (BCSF) has recently received an “Outperform” rating from analyst Paul Johnson of Keefe, Bruyette & Woods, with a price target of $16, surpassing its current ...

Stryker Corporation (NYSE: SYK) has recently been upgraded to a “Market Outperform” rating by Citizens’ analyst David Turkaly, with a price target set at $440, significantly above its current price of ...

In a recent development that may pique the interest of investors, PACCAR Inc (PCAR) has received an “Overweight” rating from Tami Zakaria of JP Morgan on December 19, 2025. This upgrade not only ...

The Eastman Chemical Company (NYSE: EMN) has recently attracted attention following a new Equal-Weight rating from Wells Fargo’s Michael Sison, issued o. The revised rating, paired with a price target ...

Generac Holdings Inc. (GNRC) received a notable upgrade to Overweight by Wells Fargo analyst Praneeth Satish o. This rating change signals renewed optimism towards the company’s growth potential, with ...

Elevance Health Inc. (ELV) found itself under scrutiny on December 19, 2025, as Deutsche Bank analyst George Hill downgraded the stock to a ‘Hold’ rating. The firm adjusted its price target to $332, ...

Air Products and Chemicals, Inc. (APD) has recently been assigned an Equal-Weight rating by Michael Sison of Wells Fargo o. This rating change signifies a cautious, yet optimistic outlook for ...

In a recent development that has caught the attention of investors, Cytokinetics, Incorporated (ticker: CYTK) received a ‘Buy’ rating from analyst Paul Choi of Goldman Sachs o. This reaffirmation ...